News
21h
News-Medical.Net on MSNEgr-1 gene identified as crucial regulator of regulatory T cells in multiple sclerosisAutoimmune diseases, such as multiple sclerosis (MS), inflammatory bowel disease (IBD), and rheumatoid arthritis (RA), affect ...
A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
5d
News-Medical.Net on MSNNeural stem cell grafts show promise for myelin repair in multiple sclerosisA study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central ...
A new study reveals that neural stem cell grafts can generate new myelin in the central nervous system, offering hope for ...
Vaccination against COVID-19 is crucial for individuals with multiple sclerosis (MS), ensuring safety and effectiveness despite immunosuppressive therapies.
New research has identified the gene Egr-1 as a critical regulator of immune balance, offering hope for autoimmune disease therapies.
Panelists discuss how emerging biomarkers like neurofilament light protein, glial fibrillary acidic protein (GFAP), cervical cord atrophy, and phase rim lesions could enable earlier identification of ...
Multiple sclerosis articles from across Nature Portfolio Multiple sclerosis is an autoimmune disease in which immune cells attack and destroy the protective myelin sheaths that surround nerve ...
Optical coherence tomography is beneficial for measuring visual changes and the impact of comorbidities in MS, NMOSD, and ...
Multiple sclerosis (MS) is a notable exception, and this example emphasizes the importance of natural history studies for understanding diseases and identifying prognostic factors.
4d
AZoLifeSciences on MSNEvidence for Neural Stem Cell-Based Therapies in Multiple SclerosisResearch indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.
Patients with relapsing-remitting multiple sclerosis (RRMS) in England, Wales and Northern Ireland can now access treatment with Biogen's oral therapy Vumerity, after NICE recommended the drug for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results